[1]
Pourmasumi, S. et al. 2024. Regulatory Effects of Various IFN-β Formulations Therapy on CXC Chemokines CXCL1 and CXCL9 Gene/Protein Levels in Relapsing-Remitting Multiple Sclerosis Patients: Regulatory effects of various IFN-β formulations therapy on CXC chemokines . Iranian Journal of Pharmaceutical Sciences. 20, 3 (Sep. 2024). DOI:https://doi.org/10.22037/ijps.v20i3.45435.